On 3/8/24, Capricor Therapeutics Inc (NASDAQ: CAPR) stock enjoyed a major increase of 16.9%, closing at $5.89. Moreover, exceptionally high trading volume at 317% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 40.2% during the last week.
Current PriceTarget Research Rating
CAPR’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Capricor Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Capricor Therapeutics has a slightly negative Power Rating of 34 and a very low Appreciation Score of 1, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment